Why in news?
Union Minister Prataprao Jadhav distributed Ayush Quality Mark certificates to hospitals and medicine manufacturers in New Delhi on 19 November 2026. The initiative provides a quality-assurance framework for Ayush products and healthcare services. It brings attention to raw-material identity, manufacturing, testing and service standards. The Ministry of Ayush has assigned implementation to the Ayush Export Promotion Council, known as AYUSHEXCIL. The certificates form part of a wider effort to make quality assessment more consistent across the sector.
What Ayush covers
Ayush includes Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa-Rigpa and Homoeopathy. The Ministry of Ayush develops policies and programmes for these healthcare systems. Their products and services involve different activities. Preparing a medicine, testing its ingredients and providing hospital care each require standards suited to that activity.
The Quality Mark framework covers products, hospitals, day-care centres, clinics, wellness centres and product-testing laboratories. It also covers facilitators of medical travel. These organisations help people arrange healthcare-related travel and services. The framework uses certification to assess compliance with the standards applicable to the organisation or product.
The roles of the institutions
AYUSHEXCIL is the Ayush Export Promotion Council. The Directorate General of Foreign Trade notified the council, and the Ministry of Ayush supports it. Its role connects the sector with export promotion and international markets. The ministry's July 2026 account identifies the council as the implementing organisation for the Quality Mark.
The initiative is linked to the Ayush Oushadhi Gunvatta evam Utpadan Samvardhan Yojana (AOGUSY). This Central Sector Scheme supports improvements in drug quality and production. Its work includes testing infrastructure, regulatory capacity, standardisation and pharmacovigilance. Pharmacovigilance means monitoring suspected adverse effects and other medicine-related problems.
How manufacturing quality is maintained
Good Manufacturing Practice (GMP) is a system for producing and controlling medicines consistently against quality standards. Quality depends on the manufacturing process as well as the final sample tested. Raw materials, equipment, premises, staff training and written procedures all influence the finished product.
For example, a manufacturer needs a defined procedure for each production step. Records show how that procedure was followed for a particular batch. Equipment and premises must be suitable for the work. Measures to prevent contamination and mix-ups help preserve the product's intended identity and composition.
The World Health Organization explains that GMP addresses risks throughout production. Testing a finished product examines the sample submitted. Control of the process supports consistency across the batch and between batches. The November certificate event highlighted manufacturing requirements, laboratory testing and transparent labelling within this wider quality system.
What laboratory standards examine
The Pharmacopoeia Commission for Indian Medicine and Homoeopathy develops official standards for Ayush drugs. A pharmacopoeia is a recognised collection of drug-quality standards. Its individual entries, called monographs, specify how a material or preparation should be identified and tested.
Identity concerns whether the material is the one specified. Purity concerns unwanted material and contaminants. Strength concerns the required amount or level of relevant constituents. The tests used depend on the particular drug. They can include botanical identification, chemical measurements and analytical methods that separate and identify compounds.
These measurements make quality assessment repeatable. A laboratory can compare a sample with a stated specification and report the result. Clear labels and manufacturing records then connect the tested product with its ingredients, producer and batch. Clinical research examines a further question: how an intervention affects a defined health condition.
Conclusion
The Quality Mark brings certification into a wider system of manufacturing controls, laboratory standards and service assessment. Its practical purpose is to make the relevant quality requirements clear and assess compliance consistently. The work depends on usable standards, capable testing facilities and records that connect products with their production history.
Sources
- Ministry of Ayush: certificate distribution, 19 November 2026
- Ministry of Ayush: Quality Mark implementation and quality-control institutions
- World Health Organization: Good Manufacturing Practice
- Pharmacopoeia Commission: monographs and drug-quality standards
- Indian Pharmacopoeia Commission: the role of pharmacopoeial standards
- Government of Delhi: Ayush healthcare systems
Lead illustration: Clarity · AI illustration of representative laboratory quality testing.